Skip to main content

Day: April 29, 2021

Chicken Soup for the Soul Entertainment’s Crackle Plus Signs Agreement with TransUnion to Allow for Improved Ad Targeting of Crackle Audience

The Addition of TransUnion data will allow Crackle Plus Advertisers to Access Robust Audience Insights Across Demographics, Finance, and Special Interests COS COB, Conn., April 29, 2021 (GLOBE NEWSWIRE) — Chicken Soup for the Soul Entertainment, Inc. (Nasdaq: CSSE), one of the largest operators of streaming advertising-supported video-on-demand (AVOD) networks, today announced Crackle Plus has signed an agreement with TransUnion (NYSE: TRU), a global information and insights company. With this agreement, Crackle Plus will utilize TransUnion’s identity and audience solutions to allow the AVOD industry leader to better serve more relevant advertising to their audiences and thus provide a higher value to agency and brand partners. “There is little doubt that streaming consumption will continue to see growth, even after a banner year...

Continue reading

Oxford Immunotec’s T-SPOT Discovery SARS-CoV-2 Test Used in DIRECT Study to Investigate the T Cell Response and COVID Vaccination in Ethnic Minority Groups

OXFORD, United Kingdom and MARLBOROUGH, Mass., April 29, 2021 (GLOBE NEWSWIRE) — Oxford Immunotec a global, high-growth diagnostics company part of PerkinElmer (NYSE: PKI), today announced that its T-SPOT®Discovery SARS-CoV-2 kit will be used for T cell testing in the DIRECT study. Oxford Immunotec is collaborating with researchers at the University of Leicester on DIRECT (Determining the Immune Response in Ethnic minority healthcare workers to COVID-19 infection). The study, funded through the National Core Studies group, is actively recruiting healthcare workers in Leicester for detailed analysis of their immune response to infection and / or vaccination (including T cells). This analysis, together with information collected through online questionnaires, will enable researchers to understand whether there are differences in...

Continue reading

Investview Shareholders Approve a Future Potential Reverse in Association with an Uplist

Eatontown, New Jersey, April 29, 2021 (GLOBE NEWSWIRE) — Investview Inc. (OTCQB: INVU) will be filing a preliminary Schedule 14C today reflecting that its shareholders acted by majority written consent to provide the Board of Directors the ability to execute a reverse split for up to 1 for 20 in conjunction with an uplist to Nasdaq. “As our FINTECH plans are generating the desired financial results, we are preparing in advance to uplist and reverse split over the next 12 months. This is in anticipation of future actions to address the Company’s capitalization. It is important to have the option to do this, so we can execute when needed,” said Joseph Cammarata, CEO Investview’s majority shareholders have agreed to give the board the ability to do up to a 1 for 20 reverse split to be utilized in connection with an uplist to the Nasdaq...

Continue reading

Kadant to Hold Earnings Conference Call on Wednesday, May 5, 2021

WESTFORD, Mass., April 29, 2021 (GLOBE NEWSWIRE) — Kadant Inc. (NYSE: KAI) announced it will release its 2021 first quarter results after the market closes on Tuesday, May 4, 2021 and will hold a webcast the next day, Wednesday, May 5, 2021 at 11:00 a.m. eastern time. During the call the Company will discuss its first quarter financial performance and future expectations. To listen to the call live, go to the “Investors” section of the Company’s website at www.kadant.com. To participate in the live question and answer session, dial 888-326-8410 within the U.S., or +1-704-385-4884 outside the U.S., and reference participant passcode 4189188. The earnings release and webcast presentation will be posted in the “Investors” section of the Company’s website. A replay of the webcast will be available on the Company’s website through June...

Continue reading

Canaan Announces Entry into Agreement for Registered Direct Placement of Approximately US$170.0 Million of its ADSs and Warrants

BEIJING, April 29, 2021 (GLOBE NEWSWIRE) — Canaan Inc. (NASDAQ: CAN) (“Canaan” or the “Company”), a leading high-performance computing solutions provider, today announced it has entered into a securities purchase agreement with certain institutional investors for a registered direct placement of approximately $170.0 million of its American Depositary Shares (“ADS”), each ADS representing 15 Class A ordinary shares of the Company, par value US$0.00000005 per share (the “Class A Ordinary Shares”), or US$12.60 per ADS. The Company has also agreed to issue to the investors warrants (the “Warrants”) to purchase up to an aggregate of 4,047,620 ADSs (representing 60,714,300 Class A Ordinary Shares), at an exercise price of $16.38 per ADS, which Warrants will have a term of three years from the date of issuance....

Continue reading

Selskabsmeddelelse nr. 05-2021

NASDAQ Copenhagen A/S                                                                                                                                                                                                           SELSKABSMEDDELELSE NR. 05-2021                            Forløb af ordinær generalforsamling den 29. april 2021 Generalforsamlingen blev afholdt i overensstemmelse med den udsendte dagsorden. Årsberetningen blev taget til efterretning. Årsrapporten blev godkendt enstemmigt og med samtlige stemmer. Vederlagsrapporten blev godkendt enstemmigt og med samtlige stemmer. Der udloddes ikke udbytte. Til bestyrelsen genvalgtes Peter Eriksen Jensen, John Staunsbjerg Dueholm, Lars Radoor Sørensen og Pernille Wendel Mehl. Grant Thorton Danmark, Stockholmsgade 45, 2100 København Ø (CVR nr. 34209936) blev valgt som revisor. Bestyrelsen...

Continue reading

HC2 Holdings to Report First Quarter 2021 Results on May 7

NEW YORK, April 29, 2021 (GLOBE NEWSWIRE) — HC2 Holdings, Inc. (“HC2” or “the Company”) (NYSE: HCHC), announced today that it will release its financial results for the first quarter 2021 on Friday, May 7, 2021 before the market opens. The Company will host an earnings conference call reviewing these results, its operations and strategy on the same day, beginning at 8:30 a.m. ET. Dial-in instructions for the conference call and the replay are outlined below. This conference call will also be broadcast live over the internet and can be accessed by all interested parties through HC2’s Investor Relations website at ir.hc2.com. To listen to the live call, please go to the “Investor Relations” section of the Company’s website at least 15 minutes prior to the start of the call to register and download any necessary audio software. For...

Continue reading

Hanmi Financial Increases Quarterly Cash Dividend By 20%

LOS ANGELES, April 29, 2021 (GLOBE NEWSWIRE) — Hanmi Financial Corporation (NASDAQ: HAFC) (“Hanmi”), the holding company for Hanmi Bank, today announced that its Board of Directors declared a cash dividend on its common stock for the 2021 second quarter of $0.12 per share, up 20% from $0.10 per share in the prior quarter. The dividend will be paid on May 27, 2021 to stockholders of record as of the close of business on May 10, 2021. “I am very pleased to announce the increase of our quarterly dividend for the second time this year,” said Bonnie Lee, President and Chief Executive Officer. “The new dividend, which reflects a 20% increase from the prior quarter, provides further evidence of the Board of Directors’ confidence in the Bank’s ability to drive profitable growth as we emerge from the pandemic and economic conditions continue...

Continue reading

Biocannabix Enters Into LOI With IAM Health GmbH

MONTREAL, April 29, 2021 (GLOBE NEWSWIRE) — Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), and its’ wholly-owned subsidiary, Biocannabix Health Corporation (the “BCX”), a company focused on Paediatric and Geriatric applications of Cannabinoid nutraceutical and medical food formulations, is delighted to announce that it has entered in a Letter of Intent (the “LOI”) with IAM Health GmbH (the “IAM”), a German based Research & Development company, to pursue a number of pre-defined research opportunities. The terms of the LOI will allow Biocannabix to hold a 51% equity interest of the combined research entity and will continue operations under the IAM Health GmbH name, which will become the Company’s brand and driver for clinical and research therapeutics. IAM HEALTH...

Continue reading

Gilat Achieves Critical Milestone in Peru with Approval to Enter Operational Phase, Unlocking Access to Recurring Revenue of Multi Million Dollars per Annum

Gilat’s network to provide broadband internet services to over a million and half people in the region of CuscoGilat to Deliver Broadband Connectivity to over a Million and Half People in PeruOperational phase reached in Cusco unlocking millions of dollars of recurring revenuePETAH TIKVA, Israel, April 29, 2021 (GLOBE NEWSWIRE) — Gilat Satellite Networks Ltd. (NASDAQ, TASE: GILT), a worldwide leader in satellite networking technology, solutions and services, announced today that it has reached a critical milestone in Peru with approval to enter the operational phase of the telecom project awarded in 2015 for an aggregate value of $108M. This phase enables the start of delivery of broadband internet services to over a million and a half people in Cusco. Entering the operational phase will enable Gilat to unlock...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.